[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363262-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363262-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hdhd5-promotes-triple-negative-breast-cancer-growth-and-drives-emt-associated-phenotypes-via-regulating-s100a4","HDHD5 promotes triple-negative breast cancer growth and drives EMT-associated phenotypes via regulating S100A4","","Purpose: Triple-negative breast cancer (TNBC) is an aggressive subtype with complete responses in fewer than 30% of patients, making new therapeutic targets and mechanistic insight essential. Methods: The study used multi-omics differential analyses to identify oncogenic factors and evaluated proliferation, migration, and invasion with CCK-8, colony formation, and transwell assays, supported by proteomics, Western blotting, and RT-qPCR. Xenograft models assessed in vivo functions of HDHD5. Results: HDHD5 is highly expressed in TNBC and correlates with poor prognosis. It enhances tumor cell growth and EMT-associated migratory and invasive phenotypes, partly via S100A4 regulation, consistent in vitro and in vivo. Conclusion: HDHD5 is a novel driver in TNBC with therapeutic and prognostic value.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hdhd5-promotes-triple-negative-breast-cancer-growth-and-drives-emt-associated-phenotypes-via-regulating-s100a4/363262/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hdhd5-promotes-triple-negative-breast-cancer-growth-and-drives-emt-associated-phenotypes-via-regulating-s100a4/363262.png","ImageObject",300,407,{"name":42,"@type":43},"Pentious","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in triple-negative breast cancer?","Question",{"text":63,"@type":64},"It targets the aggressive clinical profile of TNBC and the limited effectiveness of current chemotherapy, with complete responses in fewer than 30% of patients, motivating the search for new therapeutic targets and mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers evaluate HDHD5 functions experimentally?",{"text":68,"@type":64},"They assessed proliferation, migration, and invasion using CCK-8, colony formation, and transwell assays, used quantitative proteomics after HDHD5 knockdown, applied Western blotting and RT-qPCR to measure expression, and employed xenograft tumor models for in vivo validation.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism links HDHD5 to EMT and tumor progression?",{"text":72,"@type":64},"HDHD5 promotes EMT-associated phenotypes and increases migratory and invasive capacities in TNBC cell lines, at least in part through regulation of S100A4, supporting consistent effects on tumor growth in vitro and in vivo.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363262,1790184161,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Journal of Cancer Research and Clinical Oncology (2026) 152:101  \n[https://doi.org/10.1007/s00432-026-06477-x](https://doi.org/10.1007/s00432-026-06477-x)  \nRESEARCH  \nHDHD5 promotes triple-negative breast cancer growth and drives EMT-associated phenotypes via regulating S100A4  \nJia-Yang Cai1,2 · Yin-Ling Zhang3 · Fang-Lin Zhang3 · Qian Zhao1,2,3 · Meng-Ke Ma1,2,3 · Zhi-Min Shao1,2,3  \nReceived: 14 January 2026 / Accepted: 31 March 2026 © The Author(s) 2026  \nAbstract  \nPurpose Triple-negative breast cancer (TNBC) displays an aggressive clinicopathological profile. Despite cytotoxic chemotherapy being the primary systemic therapy, complete responses are achieved in fewer than 30% of patients, highlighting the need for new therapeutic targets and a deeper understanding of disease-driving mechanisms.  \nMethods This study identified key oncogenic factors in TNBC through multi-omics differential analyses. Cell proliferation, migration, and invasion abilities were assessed using CCK-8, colony formation, and transwell migration and invasion assays. Quantitative proteomics was applied to profile downstream protein alterations following HDHD5 knockdown. Western blotting and RT-qPCR were used to examine expression levels in different samples. Xenograft tumor model was employed to investigate the in vivo functions of HDHD5 .  \nResults HDHD5 was highly expressed in TNBC and its elevated expression was associated with poor patient prognosis. Functional studies demonstrated that HDHD5 promotes TNBC cell proliferation and colony formation, as well as enhances cell migration and invasion. Mechanistically, HDHD5 facilitates epithelial–mesenchymal transition (EMT) associated phenotypes and promotes migratory and invasive capacities in TNBC cell lines, at least in part, through regulation of S100A4 . Consistently, HDHD5 promoted TNBC tumor growth both in vitro and in vivo via S100A4 .  \nConclusion Our study reveals HDHD5 as a previously unrecognized driver of tumor progression in TNBC and highlights its potential as a therapeutic target and prognostic biomarker for this aggressive breast cancer subtype.  \nKeywords HDHD5 · Triple-negative breast cancer · S100A4 · EMT · Migration · Invasion  \nIntroduction  \nTriple-negative breast cancer (TNBC) represents a distinct subtype of breast cancer that lacks expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, and it comprises roughly 15% of  \n􀀍 Jia-Yang Cai[jiaycai@whu.edu.cn](jiaycai@whu.edu.cn)  \n􀀍 Zhi-Min Shao [zhimingshao@fudan.edu.cn](zhimingshao@fudan.edu.cn)  \n1 Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China  \n2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China  \n3 Cancer Institute, Shanghai Medical College, Fudan University, Shanghai 200032, China  \nall breast cancer diagnoses (Bianchini et al. 2022) . In contrast to other breast cancer subtypes, triple-negative breast cancer is characterized by highly aggressive clinicopathological features, including early distant metastasis, frequent relapse, and poor clinical outcomes (Bianchini et al. 2016) . Because triple-negative breast cancer lacks responsiveness to endocrine therapy and HER2-targeted agents, cytotoxic chemotherapy remains the cornerstone of systemic treatment (Bianchini et al. 2022, Bianchini et al. 2016) . However, fewer than 30% of patients achieve a complete response to standard chemotherapy, highlighting the limited effectiveness of current therapeutic options (Li et al. 2022) . Therefore, a deeper understanding of the molecular mechanisms underlying triple-negative breast cancer, together with the identification of novel therapeutic targets based on its molecular characteristics, is urgently needed.  \nMitochondria play a central role in cellular energy production and are essential for key processes including cell signaling, metabolism, apoptosis, ","cbCaimRTauV6OeT3","https://ap.wps.com/l/cbCaimRTauV6OeT3","pdf",13513024,14,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What problem does the study address in triple-negative breast cancer?\",\"answer\":\"It targets the aggressive clinical profile of TNBC and the limited effectiveness of current chemotherapy, with complete responses in fewer than 30% of patients, motivating the search for new therapeutic targets and mechanisms.\"},{\"question\":\"How did the researchers evaluate HDHD5 functions experimentally?\",\"answer\":\"They assessed proliferation, migration, and invasion using CCK-8, colony formation, and transwell assays, used quantitative proteomics after HDHD5 knockdown, applied Western blotting and RT-qPCR to measure expression, and employed xenograft tumor models for in vivo validation.\"},{\"question\":\"What mechanism links HDHD5 to EMT and tumor progression?\",\"answer\":\"HDHD5 promotes EMT-associated phenotypes and increases migratory and invasive capacities in TNBC cell lines, at least in part through regulation of S100A4, supporting consistent effects on tumor growth in vitro and in vivo.\"}]","HDHD5 promotes triple-negative breast cancer growth and drives EMT-associated phenotypes via regulating S100A4 | PDF",1790150528,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fb16e7c348d048c5c7281d0c9d73a49.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e48b8bb7df8b2b7924b7e0ca86ce2417.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e69579526b49c89f54d2660c97a3195.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4820cb9c2399afabbae97e5ec5ae6cd1.webp",980,1301]